Adagloxad simolenin

DB16082Investigational

Adagloxad simolenin is under investigation in clinical trial NCT03562637 (Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC).

Mechanism: Pharmacologically active on Hemocyanin 1
Curator reviewed
Code names: OBI-822 · OPT-821

Resolves to

Compound

UNIIUCG949AA7ZCAS1458687-85-8

Targets

Q10583KLH1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Adagloxad simolenin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account